Spots Global Cancer Trial Database for Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Official Title: Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Study ID: NCT05354076
Conditions
Interventions
Study Description
Brief Summary: To study the correlation between the content of natural IgM in patients' blood samples and liposomal doxorubicin for clinical use, and to explore the possibility of using natural IgM content to guide clinical accurate medication.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
